• SENSEX 81,583.30
    -212.85 (--0.26%)
  • BANKNIFTY 55,944.90
    417.55 (+0.75%)
  • Vishal Mega Mart
    129.30 134.50(%)
  • Reliance Industr
    1,425.80 1,115.55(%)
  • Infosys
    1,647.70 2,006.80(%)
  • Sterlite Tech.
    119.00 109.09(%)
  • HDFC Bank
    1,919.55 1,588.50(%)
  • Varun Beverages
    469.50 419.40(%)
  • ICICI Bank
    1,417.60 1,101.00(%)
  • TCS
    3,522.30 4,585.90(%)
  • Happiest Minds
    674.00 955.00(%)
  • Mazagon Dock
    3,342.85 3,778.00(%)
  • Garden Reach Sh.
    3,205.00 3,528.00(%)
  • Bharti Airtel
    1,847.50 1,373.05(%)
  • M & M
    2,993.70 2,360.45(%)
  • Kotak Mah. Bank
    2,129.90 1,679.10(%)
  • Tata Motors
    672.25 542.55(%)
  • Cochin Shipyard
    2,244.10 2,977.10(%)
  • Hind. Unilever
    2,334.10 3,034.50(%)
  • Sun Pharma.Inds.
    1,641.40 1,461.40(%)
  • St Bk of India
    790.75 679.65(%)
  • HCL Technologies
    1,738.00 2,011.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Balaxi Pharmaceuticals Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 22472.0
  • ISIN : INE618N01022
49.95 -2 (-3.92%)
  • As on 17 Jun 2025 (EOD)

  • Today’s Low

    49.76

  • Today’s High

    53.01

  • Open

    52.01

  • Perv Close

    51.99

  • 52W Low

    49.20

  • 52W High

    133.00

Key Indicators

  • P/E(TTM)

    76.85

  • Mar.Cap (₹Cr.)

    275.76

  • Div & Yield %

    0.00

  • Book Value(₹)

    23.16

  • Debt-Equity Ratio

    -3.92

  • AGM Date

    16-Jun-2025

  • EPS

    0.65

  • P/E Ratio

    76.85

Financials Ratios

  • Debt-Equity Ratio

    0.09

  • Mar.Cap (₹Cr.)

    275.76

  • RONW (%)

    -25.94

  • ROCE (%)

    20.69

Score Board

  • Equity (₹ in Cr.)

    11.04

  • BV (₹)

    23.20

  • Sales( ₹ in Cr.)

    60.99

  • NP (in Cr.)

    3.60

  • NP Var(%)

    -2.0

  • Div%

    0.0

  • CPS (₹)

    0.70

  • EPS (₹)

    0.70

  • Traded Value (₹ in Lakhs)

    275.76

  • 52 Week High

    133.00

  • 52 Week Low

    49.20

  • Price BSE

    0.0

  • Price NSE

    50.00

  • Market Capital( in Cr.)

    275.76

  • P/C Ratio

    68.00

  • P/E Ratio

    76.60

  • Price Vs.BV

    0.70

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 70.20 108.14 101.29 86.87 45.63 13.60
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 70.20 108.14 101.29 86.87 45.63 13.60
Other Income 2.40 6.60 2.75 1.81 0.59 0.89
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 72.60 114.74 104.04 88.68 46.22 14.49
EXPENDITURE :            
Raw Materials 56.49 82.10 76.92 63.33 32.83 0.00
Power and Fuel Cost 0.04 0.04 0.02 0.00 0.00 0.00
Employee Cost 5.04 4.04 2.90 1.95 1.75 0.90
Other Manufacturing Expenses 0.21 0.25 0.13 0.12 0.00 10.30
Selling and Administration Expenses 2.58 4.51 3.79 2.06 1.71 0.59
Miscellaneous Expenses 0.49 0.33 0.23 0.39 0.69 0.25
Employee Benefit Expenses 5.04 4.04 2.90 1.95 1.75 0.90
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 64.84 91.27 83.99 67.85 36.99 12.04
Operating Profit 7.75 23.48 20.05 20.83 9.24 2.44
Interest 1.66 0.51 0.10 0.15 0.05 0.00
Gross Profit 6.09 22.97 19.95 20.68 9.19 2.44
Depreciation 0.51 0.52 0.25 0.09 0.01 0.00
Profit Before Tax 5.58 22.45 19.70 20.59 9.18 2.44
Current Tax 2.04 5.17 5.00 5.46 2.69 0.47
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.11 1.06 0.03 0.00 0.00 0.00
Reported Net Profit 3.65 16.22 14.67 15.13 6.50 1.97
Extraordinary Items -0.04 0.00 0.00 0.00 0.00 0.00
Adjusted Net Profit 3.69 16.22 14.67 15.13 6.50 1.97
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 52.34 36.61 21.95 6.81 0.32 -1.65
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.50 0.00 0.00 0.00 0.00
P & L Balance carried down 55.99 52.34 36.61 21.95 6.81 0.32
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 5.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.50 0.00 0.00 0.00
Earnings Per Share-Unit Curr 3.35 15.93 14.67 15.13 6.50 6.47
Earnings Per Share(Adj)-Unit Curr 0.67 3.19 2.93 3.03 1.30 1.29
Book Value 108.07 80.35 57.91 43.25 28.11 11.58
Book Value(Adj)-Unit Curr 21.61 16.07 11.58 8.65 5.62 2.32

Shareholding Pattern

  • Promoter Group

    65.99%

  • Public Share Holding

    34.01%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 35,000,000 63.40 35,000,000 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 1,431,770 2.59 1,431,770 2
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 36,431,770 65.99 36,431,770 3
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 13,160 0.02 0 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 8,846,446 16.02 8,846,446 3
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 8,859,606 16.05 8,846,446 4
2] Non Institution
Bodies Corporate 1,978,359 3.58 1,978,359 44
Clearing Members 50 0.00 50 1
Directors of their Relatives 1,068,795 1.94 1,068,795 2
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 183,494 0.33 183,494 95
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 98,781 0.18 98,781 118
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,499,663 2.72 1,499,663 5
Individuals holding nominal share capital up to Rs. 1 lakh 3,920,226 7.10 3,782,776 9,720
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 1,166,756 2.11 1,166,756 2
Sub Total 9,916,124 17.96 9,778,674 9,987
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 55,207,500 100.00 55,056,890 9,994

Company Background

Balaxi Pharmaceuticals LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Balaxi Pharmaceuticals Ltd
  • BSE Code : 22472.0
  • ISIN : INE618N01022

  • Incorporation Year

    1942

  • Registered Office

    41/298-D2 2nd Flr Saniya Plaza
    Mahakavi Bharatiyar Road, Cochin,
    Kerala-682035

  • Telephone

    91-484-4032952/6596725

  • FAX

  • Chairman

  • Managing Director

    Ashish Maheshwari

  • Company Secretary

    Mohith Kumar Khandelwal

  • Auditor

    P Murali & Co

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    SKDC Consultants Ltd
    Surya 35 Mayflower ,
    Avenue Sowripalayam ,Road
    Mumbai - Coimbatore - 641 028

Balaxi Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Balaxi Pharma 49.95 72.59 70.20 76.85 5.99
Abbott India 31,658.15 6,097.18 5,848.91 47.56 44.71
Astrazeneca Phar 10,204.20 1,330.33 1,295.53 220.39 33.26
P & G Health Ltd 5,907.60 1,166.89 1,151.26 39.04 39.76
Glaxosmi. Pharma 3,366.50 3,866.05 3,723.49 62.06 58.72
Cipla 1,526.90 17,645.00 16,574.34 23.91 20.10
Amrutanjan Healt 700.10 437.58 421.23 39.82 20.84
Guj. Themis Bio. 349.55 174.19 169.82 78.02 44.82
Fermenta Biotec. 341.00 315.24 307.09 14.85 4.10
Bliss GVS Pharma 147.30 638.96 605.46 22.49 11.19
Ambalal Sarabhai 36.91 11.70 3.81 34.18 1.92